Chime Financial (CHYM) slides 5.9% as traders reposition ahead of upcoming earnings

Chime Financial, Inc. (CHYM) is down 5.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The drop looks most consistent with pre-earnings positioning and risk reduction ahead of Chime’s next quarterly results. With the company scheduled to report soon and short interest elevated, even modest shifts in sentiment can translate into an outsized one-day move. This could also be simple profit-taking after prior volatility rather than a single new fundamental headline.

Details:

Chime announced it plans to release first-quarter 2026 financial results on May 6, 2026 after market close, with a conference call the same day.

An 8-K filed February 25, 2026 tied to results for the fourth quarter and full year ended December 31, 2025, highlighting that the market has been trading off company-reported financial updates and guidance.

Short interest has been trending higher (as a percentage of float), which can amplify day-to-day price moves as investors hedge or cover around catalysts like earnings.

Given the timing (the trading day immediately before the scheduled release), the move may reflect uncertainty around near-term guidance, margins, or credit/transaction trends rather than any confirmed new disclosure.

Sources:

Chime Investor Relations, U.S. Securities and Exchange Commission, Stock Titan

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CHYM Insider Trading Activity

$CHYM insiders have traded $CHYM stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $CHYM stock by insiders over the last 6 months:

JAMES FEUILLE has made 0 purchases and 3 sales selling 183,397 shares for an estimated $4,957,755.
AMINE ASMEROM (Chief Accounting Officer) has made 0 purchases and 2 sales selling 84,589 shares for an estimated $1,704,972.
CHRISTOPHER R BRITT (Chief Executive Officer) sold 50,000 shares for an estimated $1,402,825
ADAM B FRANKEL (General Counsel) has made 0 purchases and 6 sales selling 13,142 shares for an estimated $333,745.
MATTHEW S NEWCOMB (Chief Financial Officer) sold 10,000 shares for an estimated $280,109

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

EARLY ACCESS

Receive CHYM Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CHYM Hedge Fund Activity

We have seen 134 institutional investors add shares of $CHYM stock to their portfolio, and 81 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FORERUNNER VENTURES MANAGEMENT, LLC added 9,031,107 shares (+inf%) to their portfolio in Q4 2025, for an estimated $227,312,963
ASHTON THOMAS PRIVATE WEALTH, LLC added 5,128,770 shares (+inf%) to their portfolio in Q4 2025, for an estimated $129,091,140
CITADEL ADVISORS LLC added 4,249,643 shares (+178.3%) to their portfolio in Q4 2025, for an estimated $106,963,514
POINT72 ASSET MANAGEMENT, L.P. added 3,574,654 shares (+353.1%) to their portfolio in Q4 2025, for an estimated $89,974,041
ICONIQ CAPITAL, LLC removed 2,992,314 shares (-19.9%) from their portfolio in Q4 2025, for an estimated $75,316,543
IEQ CAPITAL, LLC added 2,312,846 shares (+inf%) to their portfolio in Q4 2025, for an estimated $58,214,333
GENERAL ATLANTIC, L.P. added 2,050,923 shares (+10.7%) to their portfolio in Q4 2025, for an estimated $51,621,731

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$CHYM Analyst Ratings

Wall Street analysts have issued reports on $CHYM in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Goldman Sachs issued a "Buy" rating on 01/06/2026
B. Riley Securities issued a "Buy" rating on 12/11/2025

To track analyst ratings and price targets for $CHYM, check out Quiver Quantitative's $CHYM forecast page.

$CHYM Price Targets

Multiple analysts have issued price targets for $CHYM recently. We have seen 9 analysts offer price targets for $CHYM in the last 6 months, with a median target of $30.0.

Here are some recent targets:

Andrew Bauch from BMO Capital set a target price of $30.0 on 04/22/2026
Giuliano Bologna from Compass Point set a target price of $27.0 on 04/13/2026
Cassie Chan from Wells Fargo set a target price of $25.0 on 04/13/2026
Alex Markgraff from Keybanc set a target price of $30.0 on 03/04/2026
Mark Mahaney from Evercore ISI Group set a target price of $35.0 on 02/26/2026
Timothy Chiodo from UBS set a target price of $27.0 on 02/26/2026
Harry Bartlett from Rothschild & Co set a target price of $29.0 on 01/26/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.